NCT03091257 2026-03-13A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaMassachusetts General HospitalPhase 1 Active not recruiting30 enrolled
NCT04675710 2026-02-19Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting30 enrolled